Ionis Pharmaceuticals, Inc. (IONS)
27.38
+0.42
(+1.56%)
USD |
NASDAQ |
Nov 18, 16:00
27.38
0.00 (0.00%)
After-Hours: 19:17
Ionis Pharmaceuticals Total Return Level : 26.96 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 26.96 |
| November 16, 2026 | 28.01 |
| November 13, 2026 | 29.06 |
| November 12, 2026 | 27.31 |
| November 11, 2026 | 28.33 |
| November 10, 2026 | 28.19 |
| November 09, 2026 | 31.00 |
| November 06, 2026 | 39.42 |
| November 05, 2026 | 38.80 |
| November 04, 2026 | 40.15 |
| November 03, 2026 | 40.42 |
| November 02, 2026 | 41.24 |
| October 30, 2026 | 43.52 |
| October 29, 2026 | 44.39 |
| October 28, 2026 | 44.90 |
| October 27, 2026 | 43.96 |
| October 26, 2026 | 43.42 |
| October 23, 2026 | 42.93 |
| October 22, 2026 | 43.91 |
| October 21, 2026 | 44.27 |
| October 20, 2026 | 45.40 |
| October 19, 2026 | 44.38 |
| October 16, 2026 | 42.94 |
| October 15, 2026 | 44.12 |
| October 14, 2026 | 42.70 |
| Date | Value |
|---|---|
| October 13, 2026 | 42.38 |
| October 12, 2026 | 43.67 |
| October 09, 2026 | 45.28 |
| October 08, 2026 | 43.30 |
| October 07, 2026 | 44.16 |
| October 06, 2026 | 44.00 |
| October 05, 2026 | 43.50 |
| October 02, 2026 | 43.54 |
| October 01, 2026 | 44.00 |
| September 30, 2026 | 44.65 |
| September 29, 2026 | 45.89 |
| September 28, 2026 | 45.57 |
| September 25, 2026 | 44.50 |
| September 24, 2026 | 43.81 |
| September 23, 2026 | 43.93 |
| September 22, 2026 | 45.75 |
| September 21, 2026 | 44.90 |
| September 18, 2026 | 44.44 |
| September 17, 2026 | 46.75 |
| September 16, 2026 | 44.84 |
| September 15, 2026 | 47.25 |
| September 14, 2026 | 51.44 |
| September 11, 2026 | 54.21 |
| September 10, 2026 | 55.65 |
| September 09, 2026 | 56.02 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 156.50 |
| Arrowhead Pharmaceuticals, Inc. | 42.99 |
| BridgeBio Pharma, Inc. | 76.80 |
| Biogen, Inc. | 250.79 |
| TG Therapeutics, Inc. | 62.71 |